Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Laboratories Inc.

www.abbott.com

Latest From Abbott Laboratories Inc.

Reata Expands Options For Bardoxolone With New CKD Data

Once suspended due to safety issues, bardoxolone now has completed a Phase II study that showed kidney function benefit in four rare types of CKD. A pivotal study is underway, with another planned and more possible.

Clinical Trials Research & Development

Abbott Unit Aims To Settle Investor Suit

Thoratec has agreed with plaintiffs to pay $12m to settle a lawsuit alleging the company hid negative information about the company’s heart pump, thus keeping share prices artificially high. A hearing is scheduled on the settlement for next month.

Legal Issues Commercial

US FDA Plans To Standardize Review Of Blood Pressure Effects Of New Drugs

Approach is modeled after the interdisciplinary review team established more than a decade ago to review data on QT interval effects, FDA says; at a recent Duke meeting on assessing off-target pressor effects, discussion focused on lessons learned in the QT space that could be applied to studying blood pressure effects.

Drug Safety Research and Development Strategies

Wellness Market News: Nuritas-Pharmavite Peptides, Abbott Nutriton, Brain Armor, Trade Group Notes

Pharmavite tests bioactive peptides with Nuritas' AI platform; NPA questions FDA proposal to share data collected from US firms; NFL great Randy White promotes Brain Armor supplements; Abbott Nutrition sales up 4.4% for 2018; ONHA targets expanding omega-3 testing among consumers; CRN's Mister, Sidley's Bass co-chair regulatory conference; and 'Hero for the Planet' Plotkin speaks at AHPA meeting.

Commercial Dietary Supplements
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register